Peter Linde, Chief Medical Officer at Morphic Holding, Inc. (MORF), sold 23,119 shares at $64.49 ($1.5M) on 2021-03-16, disclosed to the SEC on 2021-03-17.
Open-market sale of $1.5M MORF by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.65 | 9,558 | $608K | 41.2% |
| 2 | $63.65 | 9,558 | $608K | 41.2% |
| 3 | $64.49 | 1,561 | $101K | 6.8% |
| 4 | $64.49 | 1,561 | $101K | 6.8% |
| 5 | $65.49 | 381 | $25K | 1.7% |
| 6 | $68.38 | 500 |
| $34K |
| 2.3% |
| Total | $63.90 avg | 23,119 | $1.5M | 100% |
| Filing → |